Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01604252 · ClinicalTrials.gov registry record
An Observational Study of Treatment Patterns and Effectiveness and Safety Outcomes in Advanced Basal Cell Carcinoma and Basal Cell Carcinoma Nevus Syndrome Patients(RegiSONIC)
A clinical trial, sponsored by Genentech.
- Terminated
- Registry status
- 503
- Enrollment target
NCT01604252 is a clinical trial that was terminated before completion, run by Genentech. The registered enrollment target is 503 participants.
The verdict
NCT01604252 was terminated before completion, sponsored by Genentech.
- TERMINATED
- Registry status
- 503 participants
- Enrollment target
Study Summary
This multi-center, prospective, observational cohort study will evaluate the effectiveness, safety and utilization of treatments in patients with advanced basal cell carcinoma and basal cell carcinoma nevus syndrome. The total study duration is anticipated to be a maximum of 8 years, including 3 years for patient recruitment and 5 years follow-up.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 503 participants |
| Start Date | 2012-06-20 |
| Est. Completion | 2017-04-28 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01604252
The ClinicalTrials.gov registry entry for NCT01604252 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 503 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Genentech, which has 332 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT01604252 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01604252 about?
NCT01604252 is a clinical study titled "An Observational Study of Treatment Patterns and Effectiveness and Safety Outcomes in Advanced Basal Cell Carcinoma and Basal Cell Carcinoma Nevus Syndrome Patients(RegiSONIC)". This multi-center, prospective, observational cohort study will evaluate the effectiveness, safety and utilization of treatments in patients with advanced basal cell carcinoma and basal cell carcinoma nevus syndrome. The total study duration is anticipated to be a maximum of 8 years, including 3 yea...
What is the current status of trial NCT01604252?
This trial is currently terminated. The enrollment target is 503 participants. The study started on 2012-06-20. Estimated completion is 2017-04-28.
Who is sponsoring clinical trial NCT01604252?
This trial is sponsored by Genentech, which has 332 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.